IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
IceCure Medical received notice from Nasdaq confirming it has regained compliance with the minimum bid price requirement of $1.00 per share. The determination follows a 10 consecutive business day period from June 4 to June 17, 2026, where the closing bid price met or exceeded the threshold.
Key figures
- Minimum bid price
- $1.00
- Consecutive business days
- 10
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.